Benjamin Edwards Inc. purchased a new position in M.D.C. Holdings, Inc. (NYSE:MDC – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 5,425 shares of the construction company’s stock, valued at approximately $300,000.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Sound Income Strategies LLC bought a new position in M.D.C. in the fourth quarter valued at $25,000. McGlone Suttner Wealth Management Inc. bought a new position in shares of M.D.C. during the 4th quarter valued at about $25,000. Clear Street Markets LLC purchased a new position in shares of M.D.C. during the 3rd quarter valued at about $29,000. GAMMA Investing LLC bought a new stake in M.D.C. in the 4th quarter worth approximately $34,000. Finally, Kingswood Wealth Advisors LLC purchased a new stake in M.D.C. in the fourth quarter worth approximately $40,000. Hedge funds and other institutional investors own 88.08% of the company’s stock.
Insider Buying and Selling
In other M.D.C. news, Director David E. Blackford sold 6,200 shares of the business’s stock in a transaction on Monday, March 11th. The shares were sold at an average price of $62.69, for a total transaction of $388,678.00. Following the transaction, the director now directly owns 13,534 shares of the company’s stock, valued at approximately $848,446.46. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 23.30% of the stock is currently owned by insiders.
M.D.C. Price Performance
M.D.C. (NYSE:MDC – Get Free Report) last issued its quarterly earnings data on Tuesday, January 30th. The construction company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.50 by $0.06. The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.29 billion. M.D.C. had a return on equity of 12.32% and a net margin of 8.64%. The business’s quarterly revenue was down 11.9% compared to the same quarter last year. During the same period last year, the company earned $1.08 EPS. Sell-side analysts predict that M.D.C. Holdings, Inc. will post 5.7 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of equities analysts recently commented on MDC shares. Evercore ISI cut shares of M.D.C. from an “outperform” rating to an “in-line” rating and lifted their target price for the stock from $57.00 to $63.00 in a research report on Wednesday, January 31st. StockNews.com assumed coverage on M.D.C. in a research note on Saturday, April 27th. They issued a “hold” rating for the company. Finally, Raymond James restated a “market perform” rating on shares of M.D.C. in a research report on Wednesday, February 7th. One research analyst has rated the stock with a sell rating and five have issued a hold rating to the company. According to data from MarketBeat, M.D.C. has an average rating of “Hold” and an average price target of $52.13.
Read Our Latest Stock Report on MDC
M.D.C. Company Profile
M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.
Further Reading
- Five stocks we like better than M.D.C.
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- MarketBeat Week in Review – 4/29 – 5/3
- How to Invest in Biotech Stocks
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Want to see what other hedge funds are holding MDC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for M.D.C. Holdings, Inc. (NYSE:MDC – Free Report).
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.